Phase 1 ICL Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
TrilaciclibCDK4/6-dependent Solid Tumors
Hebei Medical University Fourth Hospital100 enrolled1 locationNCT07490236
Recruiting
Phase 1
Study of SGR-1505 in Mature B-Cell Neoplasms
High-grade B-cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+23 more
Schrödinger, Inc.98 enrolled36 locationsNCT05544019
Recruiting
Phase 1Phase 2
PK/PD of Digoxin in Infants With SVHD
Single VentricleInfant ConditionsInfant, Newborn, Diseases+1 more
Duke University20 enrolled2 locationsNCT06613477
Recruiting
Phase 1
Beta-blocker Administration for Cardiomyocyte Division
Tetralogy of FallotDouble Outlet Right Ventricle
Weill Medical College of Cornell University40 enrolled3 locationsNCT04713657
Recruiting
Phase 1Phase 2
Fibrosis and the Fontan
Single Ventricle
Children's Hospital of Philadelphia145 enrolled1 locationNCT04901975
Recruiting
Phase 1
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
PhotosensitivityMicrovesicle Particle
Wright State University40 enrolled1 locationNCT04520217